Theme
The Fractured Pathway
Source
Источник: Обзор пути пациента с остеопорозом в России, включая данные клинических рекомендаций 2023 года.
Diagnostic Bottlenecks, High Dropout Rates, and the Regional Divide in Osteoporosis Biological Therapy
15%
On-Time DXA Diagnostics
Only 15% of patients receive the "gold standard" densitometry on time, creating a systemic bottleneck that forces reactive treatment—often only after a catastrophic fracture.
Clinical Pathway Architecture
| Patient Group | Treatment Regimen | Duration |
|---|---|---|
| Cohort A: First-Line Standard Therapy |
Bisphosphonates + Calcium / Vit D |
1–2 Years |
| Cohort B: High-Risk FRAX > 20% or Non-Responders |
Denosumab / Teriparatide (Biological Therapy) |
18–24 Mo. (or 6-mo inj) |
Goal: Stable T-score & No Fractures
Risk: Hypercalcemia & Intolerance
Key Journey Breakdowns
The Silent Dropout
An alarming 40% of patients abandon first-line bisphosphonates because internal bone remodeling lacks immediate obvious effects.
Severe Regional Disparities
Specialist shortages and medical consilium delays mean regional patients wait up to 1.5 years to access life-changing biologics compared to Moscow.
Diagnostic Wait Barrier
DXA scanning suffers from a severe backlog, keeping crucial targeted treatments out of reach for 3 to 6 months in regional queues.
Recommendation: Shift to Proactive Management
1. Decentralize Diagnostics
Leverage telemedicine for specialist reviews and decentralize DXA access to aggressively cut the initial 3–6 month delay.
Leverage telemedicine for specialist reviews and decentralize DXA access to aggressively cut the initial 3–6 month delay.
2. Implement Adherence Tracking
Counter the 40% dropout rate via targeted patient education in Year 1, explaining that "invisible" bone remodeling prevents future fractures.
Counter the 40% dropout rate via targeted patient education in Year 1, explaining that "invisible" bone remodeling prevents future fractures.
3. Fast-Track Biologicals
Standardize "fast-track" criteria (FRAX > 20%) to safely bypass prolonged regional medical consortium approvals for high-risk profiles.
Standardize "fast-track" criteria (FRAX > 20%) to safely bypass prolonged regional medical consortium approvals for high-risk profiles.
AbbreviationsQuick
ИМТ — индекс массы тела; ОМС — обязательное медицинское страхование; DXA — двухэнергетическая рентгеновская абсорбциометрия (денситометрия); FRAX — алгоритм оценки риска переломов; P1NP — маркер костного метаболизма.
Bibliography1
- Клинические рекомендации по остеопорозу (2023).
👀 View Mode